New Drug Approved for Osteoporosis - KCBD NewsChannel 11 Lubbock

11/26/02

New Drug Approved for Osteoporosis

It's called Teriparatide, and it's been approved for the treatment of Osteoporosis in postmenopausal women who are at high risk for having a fracture. Daily injections of Teriparatide stimulate new bone formation leading to increased bone mineral density.

The drug is manufactured by Eli Lilly and Company of Indianapolis, Indiana and will be marketed under the trade name Forteo. For more information, you can (click here).

The drug is also approved to increase bone mass in men with primary or Hypogonadal Osteoporosis who are at high risk for fracture. Teriparatide is a portion of human parathyroid hormone which is the primary regulator of calcium and phosphate metabolism in bones.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.